Matthias Aizenberg

Matthias Aizenberg

Healthcare Innovation Consultant
Matthias Aizenberg is a seasoned expert in the Healthcare industry. He explores digital health, clinical processes, and healthcare management strategies. Matthias has a deep interest in pharmaceutical and healthcare innovation and is a well-trusted resource for biopharma professionals.
Galapagos Shifts Strategy, Considers Selling Cell Therapy Unit
Research & Development Galapagos Shifts Strategy, Considers Selling Cell Therapy Unit

In a bold maneuver to realign its strategic focus, Belgian pharmaceutical firm Galapagos is contemplating the sale of its cell therapy unit, a move that represents a significant departure from its initial restructuring plan. Originally, this unit was poised to become the cornerstone of a strategic

TraMA: New RNA-Based Method to Assess Biological Aging
Tech & Innovation TraMA: New RNA-Based Method to Assess Biological Aging

In the ever-evolving world of biopharma and medical research, experts like Ivan Kairatov are at the frontier of innovation. With profound expertise in technology and development within the sector, Ivan sheds light on a groundbreaking development that could redefine how we understand aging. The

Pivoting From Setbacks: Can Psychedelics Reshape Mental Health?
Research & Development Pivoting From Setbacks: Can Psychedelics Reshape Mental Health?

In the ever-evolving landscape of biotechnology and pharmaceuticals, Ivan Kairatov stands as a respected authority, particularly in tech and innovation within the biopharma sector. He joins us today to discuss recent developments concerning a compound known as inidascamine. Originally developed by

Will Nanotechnology Revolutionize Algae Biofuel Production?
Tech & Innovation Will Nanotechnology Revolutionize Algae Biofuel Production?

Recent strides in nanotechnology have opened up new possibilities in sustainable biofuel production, specifically from microalgae. This cutting-edge approach offers transformative potential that could reshape energy industries by improving the yield and efficiency of biofuel from algae, a promising

Will Blenrep Transform Multiple Myeloma Treatment in Europe?
Management & Regulatory Will Blenrep Transform Multiple Myeloma Treatment in Europe?

With multiple myeloma cases surpassing 50,000 annually across Europe, the quest for a more effective treatment has never been more urgent. Despite its classification as a rare cancer, its profound impact on affected individuals and healthcare systems is undeniable. Imagine a treatment that could

Innovative Glioblastoma Trial Targets Early Immunotherapy Use
Research & Development Innovative Glioblastoma Trial Targets Early Immunotherapy Use

Glioblastoma is an aggressive form of brain cancer with a median survival rate of just nine months post-diagnosis. This grim statistic raises important questions about the effectiveness of current treatments and the desperate need for new approaches. Consider the journey of many patients, whose

Doximity: Stock Dip a Strategic Entry or Valuation Concern?
Tech & Innovation Doximity: Stock Dip a Strategic Entry or Valuation Concern?

In recent discussions surrounding healthcare technology, Doximity emerges as a key player, leveraging AI-driven tools and telehealth services crafted mainly for physicians. As the industry landscape changes, the company garners attention not just for its innovative products but also for its

Are States Ready to Protect Your Brain Data Privacy?
Tech & Innovation Are States Ready to Protect Your Brain Data Privacy?

In an age where technology intertwines with daily life, the question looms larger than ever: how secure is the information derived from our very minds? As consumer-grade neurotechnology becomes as ubiquitous as smartphones and smartwatches, the potential for both innovation and intrusion grows.

Stem Cell Trial Frees Kidney Recipients from Lifelong Meds
Research & Development Stem Cell Trial Frees Kidney Recipients from Lifelong Meds

A groundbreaking approach at the University of Wisconsin School of Medicine and Public Health has illuminated a potentially transformative treatment for kidney transplant recipients, potentially freeing them from lifelong dependency on anti-rejection medications. This development, centered around

Pandemic Stressors Linked to Accelerated Brain Aging
Research & Development Pandemic Stressors Linked to Accelerated Brain Aging

What if the unseen stressors of a global health crisis were aging our brains, even if they are never infected by the virus itself? As society grapples with the aftermath of the COVID-19 pandemic, new research uncovers an unexpected consequence: accelerated brain aging due to non-infection-related

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later